1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. APELLIS PHARMACEUTICALS INC
Apellis Pharmaceuticals Inc XNAS: APLS

Apellis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

Read More
19.94 -0.59 (-2.87%)
36.03% Fall from 52W High
2.3M
XNAS Volume

XNAS 16 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
36.3 / 100
Momentum Score
Technically Neutral
42.4 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
35
1Yr Price target upside is 74%
18 analysts

10

S

11

W

2

O

2

T

SWOT Analysis

Apellis Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..